Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Explore clinical trials studying Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative. Study availability and eligibility vary by location and protocol.

154 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative trial results

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

NCT02092324

Conditions
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

NCT00274820

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +16 more
Locations
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions